These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 27828694)

  • 1. Efficacy of Prazosin in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.
    Singh B; Hughes AJ; Mehta G; Erwin PJ; Parsaik AK
    Prim Care Companion CNS Disord; 2016 Jul; 18(4):. PubMed ID: 27828694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of the efficacy and safety of prazosin versus placebo for the treatment of nightmares and sleep disturbances in adults with posttraumatic stress disorder.
    George KC; Kebejian L; Ruth LJ; Miller CW; Himelhoch S
    J Trauma Dissociation; 2016; 17(4):494-510. PubMed ID: 26835889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of prazosin on sleep disturbances in post-traumatic stress disorder: a systematic review and meta-analysis.
    Zhang Y; Ren R; Sanford LD; Yang L; Ni Y; Zhou J; Zhang J; Wing YK; Shi J; Lu L; Tang X
    Sleep Med; 2020 Mar; 67():225-231. PubMed ID: 31972510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prazosin in Children and Adolescents With Posttraumatic Stress Disorder Who Have Nightmares: A Systematic Review.
    Akinsanya A; Marwaha R; Tampi RR
    J Clin Psychopharmacol; 2017 Feb; 37(1):84-88. PubMed ID: 27930498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prazosin treatment of nightmares related to posttraumatic stress disorder.
    Dierks MR; Jordan JK; Sheehan AH
    Ann Pharmacother; 2007 Jun; 41(6):1013-7. PubMed ID: 17504838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of nightmares with prazosin: a systematic review.
    Kung S; Espinel Z; Lapid MI
    Mayo Clin Proc; 2012 Sep; 87(9):890-900. PubMed ID: 22883741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin for treating sleep disturbances in adults with posttraumatic stress disorder: a systematic review and meta-analysis of randomized controlled trials.
    Khachatryan D; Groll D; Booij L; Sepehry AA; Schütz CG
    Gen Hosp Psychiatry; 2016; 39():46-52. PubMed ID: 26644317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prazosin for treatment of nightmares related to posttraumatic stress disorder.
    Taylor HR; Freeman MK; Cates ME
    Am J Health Syst Pharm; 2008 Apr; 65(8):716-22. PubMed ID: 18387899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.
    Raskind MA; Peskind ER; Kanter ED; Petrie EC; Radant A; Thompson CE; Dobie DJ; Hoff D; Rein RJ; Straits-Tröster K; Thomas RG; McFall MM
    Am J Psychiatry; 2003 Feb; 160(2):371-3. PubMed ID: 12562588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prazosin for treatment of post-traumatic stress disorder: a systematic review and meta-analysis.
    Reist C; Streja E; Tang CC; Shapiro B; Mintz J; Hollifield M
    CNS Spectr; 2021 Aug; 26(4):338-344. PubMed ID: 32362287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotherapeutic and pharmacological agents for post-traumatic stress disorder with sleep disorder: network meta-analysis.
    Huang CY; Zhao YF; Zhang ZX; Liu RB; Liu JL; Li XZ; Luo J; Yue L; Zhang C
    Ann Med; 2024 Dec; 56(1):2381696. PubMed ID: 39061119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy for sleep disturbances in post-traumatic stress disorder (PTSD): A network meta-analysis.
    Lappas AS; Glarou E; Polyzopoulou ZA; Goss G; Huhn M; Samara MT; Christodoulou NG
    Sleep Med; 2024 Jul; 119():467-479. PubMed ID: 38795401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative meta-analysis of prazosin and imagery rehearsal therapy for nightmare frequency, sleep quality, and posttraumatic stress.
    Seda G; Sanchez-Ortuno MM; Welsh CH; Halbower AC; Edinger JD
    J Clin Sleep Med; 2015 Jan; 11(1):11-22. PubMed ID: 25325592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prazosin effects on objective sleep measures and clinical symptoms in civilian trauma posttraumatic stress disorder: a placebo-controlled study.
    Taylor FB; Martin P; Thompson C; Williams J; Mellman TA; Gross C; Peskind ER; Raskind MA
    Biol Psychiatry; 2008 Mar; 63(6):629-32. PubMed ID: 17868655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials.
    De Berardis D; Marini S; Serroni N; Iasevoli F; Tomasetti C; de Bartolomeis A; Mazza M; Tempesta D; Valchera A; Fornaro M; Pompili M; Sepede G; Vellante F; Orsolini L; Martinotti G; Di Giannantonio M
    Curr Drug Targets; 2015; 16(10):1094-106. PubMed ID: 25944011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A parallel group placebo controlled study of prazosin for trauma nightmares and sleep disturbance in combat veterans with post-traumatic stress disorder.
    Raskind MA; Peskind ER; Hoff DJ; Hart KL; Holmes HA; Warren D; Shofer J; O'Connell J; Taylor F; Gross C; Rohde K; McFall ME
    Biol Psychiatry; 2007 Apr; 61(8):928-34. PubMed ID: 17069768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha1-adrenergic antagonist prazosin improves sleep and nightmares in civilian trauma posttraumatic stress disorder.
    Taylor F; Raskind MA
    J Clin Psychopharmacol; 2002 Feb; 22(1):82-5. PubMed ID: 11799347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder.
    Raskind MA; Thompson C; Petrie EC; Dobie DJ; Rein RJ; Hoff DJ; McFall ME; Peskind ER
    J Clin Psychiatry; 2002 Jul; 63(7):565-8. PubMed ID: 12143911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
    Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
    N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
    Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C
    Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.